Microdosing LSD Fails to Ease ADHD Symptoms in Small Trial

Watchdoq March 19, 2025
(MedPage Today) -- Low-dose treatment with lysergic acid diethylamide (LSD) failed to improve symptoms of attention deficit-hyperactivity disorder (ADHD) in adults, a double-blind randomized phase IIa trial showed.
After 6 weeks, the group who...

Read Full Article